Ifosamide, epirubicin and granulocyte co
โ
M. Arland; S. Leuner; S. Lange; R. Bartsch; C. Kahl; A. Florschรผtz; A. Franke; H
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 67 KB
## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and GโCSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and GโCSF for PBPC